Abstract:This study analysed the relationship between serum progesterone/oestradiol concentrations and IVF pregnancy outcomes in gonadotrophin-releasing hormone agonist protocols. A total of 2921 infertile women undergoing IVF were assigned to four groups according to serum progesterone and oestradiol concentrations on the day of human chorionic gonadotrophin (HCG) administration: group 1 (control) progesterone<3.34 nmol/l and oestradiol<19,124 pmol/l; group 2 (high oestradiol); group 3 (high progesterone); group 4 (high progesterone and high oestradiol). Compared with group 1, group 4 had lower clinical pregnancy and live birth rates as well as the highest ectopic pregnancy rate (29.15% versus 45.91%; 18.67% versus 34.34%; 18.10% versus 5.82%; P<0.05). Group 3 had lower clinical pregnancy and live birth rates per embryo-transfer cycle (29.78% versus 45.91%; 20.28% versus 34.34%, respectively; P<0.05). Clinical pregnancy rates were similar in frozen-thawed embryo transfers (FET) among the four groups. In conclusion, elevated progesterone was detrimental to live birth rates. High serum oestradiol concentration on HCG day did not affect the IVF pregnancy outcome. In combination with the elevated progesterone, high oestradiol concentrations had a potential negative effect. For these patients, FET should be suggested to improve the pregnancy outcomes. The aim of this study was to analyse the relationship between serum progesterone/oestradiol concentrations and IVF pregnancy outcomes in gonadotrophin-releasing hormone agonist protocols. A total of 2921 infertile women undergoing IVF were assigned to four groups according to their serum progesterone and oestradiol concentrations on the day of human chorionic gonadotrophin (HCG) administration: group 1 (control) progesterone<3.34 nmol/l and oestradiol<19,124 pmol/l; group 2 (high oestradiol); group 3 (high progesterone); group 4 (high progesterone and high oestradiol). Compared with group 1, patients in group 4 had lower clinical pregnancy (29.15% versus 45.91%) and live birth rates (18.67% versus 34.34%) as well as the highest ectopic pregnancy rate (18.1% versus 5.82%) (all P<0.05). Those in group 3 had lower clinical pregnancy and live birth rates per embryo transfer cycle (29.78% versus 45.91%; 20.28% versus 34.34%, respectively, P<0.05). Embryo quality appeared to be unaffected since similar clinical pregnancy rates in frozen-thawed embryo transfer (FET) cycles among the four groups. In conclusion, elevated progesterone was detrimental to live birth rates. A high serum oestradiol concentration on the day of HCG administration did not affect the IVF pregnancy outcome. In combination with the elevated progesterone and oestradiol concentrations had a potential negative effect. For these patients, FET should be suggested to improve the pregnancy outcomes.

Impact of Progesterone Level of Late Follicular Phase on Outcome of in Vitro Fertilization

The effect of progesterone level prior to oocyte retrieval on the numbers of oocytes retrieved and embryo quality in IVF treatment cycles: an analysis of 2,978 cycles

The effect of elevated progesterone levels before oocyte retrieval in women undergoing ovarian stimulation for IVF treatment on the genomic profile of peri-implantation endometrium.

A Clinical Study on the Level of Serum Low Progesterone about Luteal Phase Support for Partial Vaginal Delivery in Assisted Reproductive Technology

Recurrent Ivf Failure Is Associated With Elevated Progesterone On The Day Of Hcg Administration

Comparison of Progesterone Measurement on Day Of, and Day After, HCG Administration in IVF–embryo Transfer Cycles

Impact of progesterone level after HCG administration on the outcome of IVF in long GnRH-agonist pituitary suppression protocol

The Impact of Late Follicular Phase Progesterone Elevation on Cumulative Live Birth Rate and Embryo Quality in 4072 Freeze-All Cycles.

Association of the serum progesterone level on the day of HCG injection and the outcome of in vitro fertilization and embryo transfer

Impact of Progesterone on Inhibins During Controlled Ovarian Stimulation

Negative Effect of Elevated Progesterone before hCG Administration on Outcome of in vitro Fertilization

Effects of high progesterone on outcomes of in vitro fertilization-embryo transfer in patients with different ovarian responses.

Impact of Serum Progesterone Levels on Clinical Outcome of in Vitro Fertilization and Embryo Transfer

Effect of serum progesterone variation in late follicular phase on clincal outcome in women undergoing IVF-ET with standard long protocols

Effect of serum estradiol and progesterone level and progesterone/estradiol ratio on the day of human chorionic gonadotropin administration in pregnancy outcome of in vitro fertilization-embryo transplantation

Effect of HCG-day serum progesterone and oestradiol concentrations on pregnancy outcomes in GnRH agonist cycles

Exploration of Factors and Mechanism of Serum Progesterone Level Rise on Late Follicular Phase

Effect Modification by Developmental Stage of Embryos on the Association Between Late Follicular Phase Progesterone Elevation and Live Birth in Fresh Transfers.

Influence of ovarian high response on pregnancy outcome of in vitro fertilization and embryo transfer

High progesterone levels on the day after HCG injection has no effect on clinical pregnancy outcomes in in vitro fertilization-embryo transfer

Impact of transitory hyperprolactinemia on clinical Outcome of in vitro fertilization and embryo transfer